Table 1

Anthropometric and cardiometabolic risk factors and glycemic control at baseline (n = 10) and at 1 (n = 10) and 5 (n = 7) years following GB surgery

Baseline1 yearP value5 yearsP valueP value§
Weight (kg)121.9 ± 22.181.9 ± 15.8<0.0001**93.6 ± 21.0<0.0001**<0.01*
BMI (kg/m2)43.5 ± 7.529.3 ± 5.4<0.0001**33.8 ± 7.5<0.0001**<0.01*
HbA1c (%)8.1 ± 1.38.3 ± 1.40.479.8 ± 1.90.150.26
HbA1c (mmol/mol)65 ± 14.267 ± 15.30.4784 ± 20.80.150.26
Basal insulin (units/day)53.0 ± 29.723.0 ± 15.60.0005**31.1 ± 22.80.02*0.17
Basal insulin (units/kg/day)0.42 ± 0.190.27 ± 0.130.0005**0.37 ± 0.170.0021*0.174
Insulin pump, n (%)6 (60)6 (60)5 (71)
Multiple daily injections, n (%)4 (40)4 (40)2 (29)
Systolic blood pressure (mmHg)123.6 ± 8.3112.6 ± 11.30.003*118.7 ± 14.10.450.19
Diastolic blood pressure (mmHg)72.8 ± 8.369.7 ± 4.20.3272.4 ± 7.20.970.57
HDL (g/dL)61.5 ± 18.463.0 ± 11.80.880.5 ± 16.70.04*0.004*
LDL (g/dL)102.3 ± 20.492.8 ± 20.50.4191.5 ± 26.30.440.95
Total cholesterol (g/dL)185.4 ± 30.9172.7 ± 24.20.59195.3 ± 27.50.720.07
Triglycerides (g/dL)112.8 ± 55.180.6 ± 43.60.004*111.2 ± 109.50.120.29
Microalbumin (mg/L)62.2 ± 14221.5 ± 26.70.3414.2 ± 16.30.290.07
  • Data are presented as mean ± SD, unless otherwise noted.

  • 1 year compared with baseline.

  • 5 years compared with baseline.

  • § 5 years compared with 1 year.

  • * Significant at P < 0.05.

  • ** Significant at P < 0.001.